
Cardiovascular And Soft Tissue Repair Patch
Cardiovascular & Soft Tissue Repair Patch Market Forecasts to 2030 - Global Analysis By Product Type (Vascular Patches, Cardiac Patches, Orthopedic Repair Patches, Dural Repair Patches, Hernia Repair Patches, Breast Reconstruction Patches and Other Product Types), Material Type, Application, End User and By Geography

According to Stratistics MRC, the Global Cardiovascular & Soft Tissue Repair Patch Market is accounted for $5.0 billion in 2024 and is expected to reach $9.0 billion by 2030 growing at a CAGR of 10.1% during the forecast period. Cardiovascular and Soft Tissue Repair Patches are medical devices used in surgical procedures to repair damaged or weakened tissues in the cardiovascular system or soft tissues elsewhere in the body. These patches are typically made from biocompatible materials, such as synthetic polymers or biological tissues, that are compatible with the body's natural healing processes. In cardiovascular surgeries, these patches are commonly used to repair defects in the heart's walls, such as septal defects or congenital heart defects, or to reinforce weakened areas of blood vessels, such as aneurysms or arteriotomies.
According to the article published by PubMed Central in August 2021, a cross-sectional study was performed on 500 participants in Saudi Arabia, which showed that the prevalence of abdominal hernia was 38.8 percent and the participants in 18-25 years had less prevalence of 21.2 percent.
Market Dynamics:
Driver:
Rising prevalence of cardiovascular disease and soft tissue injuries
Cardiovascular diseases, including heart attacks and congenital heart defects, becoming increasingly common due to factors like aging populations, lifestyle changes, and genetic predispositions, there is a growing demand for effective surgical interventions. Similarly, the incidence of soft tissue injuries, such as hernias and abdominal wall defects, is on the rise due to factors like increased physical activity and trauma. This surge in medical conditions requiring surgical repair boosts the demand for advanced repair patches. These patches offer reliable solutions for reinforcing or replacing damaged tissues, enhancing surgical outcomes and patient recovery driving the markets growth.
Restraint:
High cost of procedures
Advanced medical devices often come with substantial costs due to the sophisticated materials and technologies involved in their development and manufacturing. Consequently, the overall expense of surgical procedures using these patches can be prohibitive for many patients, particularly those without adequate health insurance coverage or in regions with limited healthcare funding. Therefore, the financial challenges associated with these procedures hinder the widespread adoption and growth of the cardiovascular and soft tissue repair patch market.
Opportunity:
Advancements in material science and technology
Innovations in biocompatible materials, such as bioengineered tissues, synthetic polymers, and nanomaterials, have led to the development of more effective, durable, and versatile repair patches. These cutting-edge materials improve the patches' ability to integrate with natural tissues, reduce the risk of rejection, and enhance the overall healing process. In addition technological advancements have also enabled the creation of patches with specialized features, such as drug-eluting properties, which can deliver medications directly to the repair site to prevent infection and promote healing leading to increased adoption and expanded use of cardiovascular and soft tissue repair patches.
Threat:
Stringent regulatory requirements
Regulatory agencies, such as the FDA and EMA, impose rigorous standards for safety, efficacy, and quality, requiring extensive clinical testing and documentation. This leads to prolonged development timelines and increased costs for manufacturers, who must invest significant resources to meet these stringent criteria. As a result, stringent regulatory requirements can limit the availability of new and improved cardiovascular and soft tissue repair patches, hindering market growth and delaying patient access to cutting-edge treatments.
Covid-19 Impact
Initially, lockdowns and resource allocation towards COVID-19 cases led to a decline in elective surgeries, including those requiring repair patches. This caused a temporary dip in market growth. However, as healthcare systems adapted, procedures resumed, and the market recovered. The focus on hygiene might have also driven aseptic patch adoption. Overall, after a temporary setback, the market is expected to return to its pre-pandemic growth trajectory, fueled by the rising prevalence of cardiovascular diseases and advancements in patch technology.
The cardiac patches segment is expected to be the largest during the forecast period
The cardiac patches is expected to be the largest during the forecast period as cardiac patches are often used in minimally invasive heart surgeries. This minimally invasive approach is a major trend in cardiovascular treatments, and cardiac patches play a key role in facilitating it. As minimally invasive procedures become more prevalent, the demand for cardiac patches is expected to rise. Moreover, effective cardiac patches can promote tissue regeneration, improve heart function, and reduce complications. This translates to better patient outcomes, leading to a higher adoption rate by surgeons and increased demand for these patches.
The vascular repair & reconstruction segment is expected to have the highest CAGR during the forecast period
The vascular repair & reconstruction segment is expected to have the highest CAGR during the forecast period because these procedures necessitate strong, durable, and biocompatible patches that can withstand the pressure of blood flow. This drives innovation in patch materials, with a focus on functionalities specifically suited for vascular applications. Further it also encompasses various procedures, from treating aneurysms to peripheral artery disease. The need for different patch types based on the specific application creates a diversified market for various patch technologies.
Region with largest share:
North America is projected to hold the largest market share during the forecast period due to the rising prevalence of cardiac diseases, the presence of a large number of pharmaceutical companies, growing research and development expenditure, and increasing incidences of hernia disorders. For instance, according to data from the Centers for Disease Control and Prevention in July 2022, heart disease is one of the leading causes of death in the United States. Among all the heart diseases coronary heart disease is the most common type of heart disease and about 20.1 million adults age 20 and older have coronary heart disease in the United States drives the growth of the market in this region.
Region with highest CAGR:
Asia Pacific is projected to hold the highest CAGR over the forecast period owing to rapid developments in healthcare infrastructure, growing trends of minimally invasive surgical procedures, rising incidence of cardiac disease, increasing medical tourism, rapid economic expansion in several countries such as China and India, rising geriatric population, and increasing burden of chronic disorders, Asia Pacific is expected to register the fastest growing rate in the coming years. Additionally raising awareness about the importance of early diagnosis and detection of congenital cardiac disorders, as well as quick treatment propels the market.
Key players in the market
Some of the key players in Cardiovascular & Soft Tissue Repair Patch market include Abbott, Admedus, Atriummed, B.Braun, Bard Peripheral Vascular Inc., Baxter, CorMatrix, Cryolife, Inc., Edwards Life Sciences Corporation, Glycar SA Pty Ltd., Integra LifeSciences Corporation, LabCor, LeMaitre Vascular Inc., Maverick Bioscience, Neovasc, Novomedics, Southern Lights Biomaterials, TEI Biosciences Inc., Terumo Medical Corporation and W.L. Gore & Associates, Inc.
Key Developments:
In April 2024, Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK).
In April 2024, Baxter Announces Mission and Logo for Proposed Kidney Care Company Vantive. The Vantive mission, Extending Lives, Expanding Possibilities, will guide and inspire the proposed company, which will focus on vital organ therapies for acute and chronic kidney diseases and beyond.
In March 2024, Abbott, and the Real Madrid Foundation announced the extension of their partnership through Real Madrid's 2026-27 season. Abbott will remain Global Health Sciences and Nutrition Partner of Real Madrid Football Club and Global Partner of the Real Madrid Foundation.
Product Types Covered:
• Vascular Patches
• Cardiac Patches
• Orthopedic Repair Patches
• Dural Repair Patches
• Hernia Repair Patches
• Breast Reconstruction Patches
• Other Product Types
Material Types Covered:
• Biologic Patches
• Synthetic Patches
Applications Covered:
• Vascular Repair & Reconstruction
• Aneurysm Repair
• Pericardial Repair
• Dural Repair
• Soft Tissue Repair
• Cardiac Repair
• Other Applications
End Users Covered:
• Ambulatory Surgical Centers (ASCs)
• Hospitals
• Specialty Clinics
• Research & Academic Institutions
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Cardiovascular & Soft Tissue Repair Patch Market, By Product Type
5.1 Introduction
5.2 Vascular Patches
5.3 Cardiac Patches
5.4 Orthopedic Repair Patches
5.5 Dural Repair Patches
5.6 Hernia Repair Patches
5.7 Breast Reconstruction Patches
5.8 Other Product Types
6 Global Cardiovascular & Soft Tissue Repair Patch Market, By Material Type
6.1 Introduction
6.2 Biologic Patches
6.2.1 Xenografts
6.2.2 Allografts
6.3 Synthetic Patches
6.3.1 Polytetrafluoroethylene (PTFE)
6.3.2 Polyester
6.3.3 Polypropylene
6.3.4 Other Synthetic Patches
7 Global Cardiovascular & Soft Tissue Repair Patch Market, By Application
7.1 Introduction
7.2 Vascular Repair & Reconstruction
7.3 Aneurysm Repair
7.4 Pericardial Repair
7.5 Dural Repair
7.6 Soft Tissue Repair
7.7 Cardiac Repair
7.7.1 Congenital Heart Defects
7.7.2 Valve Repair
7.8 Other Applications
8 Global Cardiovascular & Soft Tissue Repair Patch Market, By End User
8.1 Introduction
8.2 Ambulatory Surgical Centers (ASCs)
8.3 Hospitals
8.4 Specialty Clinics
8.5 Research & Academic Institutions
8.6 Other End Users
9 Global Cardiovascular & Soft Tissue Repair Patch Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Abbott
11.2 Admedus
11.3 Atriummed
11.4 B.Braun
11.5 Bard Peripheral Vascular Inc.
11.6 Baxter
11.7 CorMatrix
11.8 Cryolife, Inc.
11.9 Edwards Life Sciences Corporation
11.10 Glycar SA Pty Ltd.
11.11 Integra LifeSciences Corporation
11.12 LabCor
11.13 LeMaitre Vascular Inc.
11.14 Maverick Bioscience
11.15 Neovasc
11.16 Novomedics
11.17 Southern Lights Biomaterials
11.18 TEI Biosciences Inc.
11.19 Terumo Medical Corporation
11.20 W.L. Gore & Associates, Inc.
List of Tables
1 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Region (2021-2030) ($MN)
2 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Product Type (2021-2030) ($MN)
3 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Vascular Patches (2021-2030) ($MN)
4 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Cardiac Patches (2021-2030) ($MN)
5 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Orthopedic Repair Patches (2021-2030) ($MN)
6 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Dural Repair Patches (2021-2030) ($MN)
7 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Hernia Repair Patches (2021-2030) ($MN)
8 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Breast Reconstruction Patches (2021-2030) ($MN)
9 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Other Product Types (2021-2030) ($MN)
10 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Material Type (2021-2030) ($MN)
11 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Biologic Patches (2021-2030) ($MN)
12 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Xenografts (2021-2030) ($MN)
13 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Allografts (2021-2030) ($MN)
14 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Synthetic Patches (2021-2030) ($MN)
15 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Polytetrafluoroethylene (PTFE) (2021-2030) ($MN)
16 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Polyester (2021-2030) ($MN)
17 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Polypropylene (2021-2030) ($MN)
18 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Other Synthetic Patches (2021-2030) ($MN)
19 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Application (2021-2030) ($MN)
20 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Vascular Repair & Reconstruction (2021-2030) ($MN)
21 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Aneurysm Repair (2021-2030) ($MN)
22 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Pericardial Repair (2021-2030) ($MN)
23 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Dural Repair (2021-2030) ($MN)
24 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Soft Tissue Repair (2021-2030) ($MN)
25 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Cardiac Repair (2021-2030) ($MN)
26 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
27 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Valve Repair (2021-2030) ($MN)
28 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Other Applications (2021-2030) ($MN)
29 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By End User (2021-2030) ($MN)
30 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Ambulatory Surgical Centers (ASCs) (2021-2030) ($MN)
31 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Hospitals (2021-2030) ($MN)
32 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Specialty Clinics (2021-2030) ($MN)
33 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Research & Academic Institutions (2021-2030) ($MN)
34 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY

We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?

Assured Quality
Best in class reports with high standard of research integrity

24X7 Research Support
Continuous support to ensure the best customer experience.

Free Customization
Adding more values to your product of interest.

Safe & Secure Access
Providing a secured environment for all online transactions.

Trusted by 600+ Brands
Serving the most reputed brands across the world.